{"status":"OK","data":{"advertisement":{"id":246004,"title":"REQUEST FOR QUOTATION no. 22 03 2024 WN - Purchase and delivery / granting of access to the license of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling software.","partial_offer_allowed":false,"publication_date":"2024-03-26","submission_deadline":"2024-03-29 23:59:59","planned_sign_date":"2024-04-01","supplementary_orders":null,"terms_of_contract_change":"The Ordering Party provides for the possibility of amending the terms of the contract concluded as a result of this procedure:\na.\tin the event of a change in applicable legislation if it becomes necessary to adapt the content of the agreement to the current state of the law (including applicable standards),\nb.\tin the event that the necessity to introduce changes results from changes in the guidelines, recommendations or decisions issued by the Institution which granted the funds for financing the agreement,\nc.\tin the event of a change in the rate of goods tax on a product which is the subject of the agreement, \nd.\textension of the license period - the Ordering Party reserves the option to renew the license for additional years during the duration of the Project. Before the end of the current license period, the Ordering Party will request the Supplier to send a quote for the following year. The Ordering Party reserves the right to renew the license if the price for the following year is no more than 10% higher than the price for the current year.\ne.\tcontract duration - the Ordering Party reserves the right to amend the expected date of contract execution as a result of changes in the scope of the signed agreement for the co-financing of the Projects (extension of the duration of the Projects or their stages),\nf.\toccurrence of force majeure - the Ordering Party reserves the right to amend the terms of the contract concluded as a result of this procedure also in the event of the occurrence of force majeure understood as an event that substantially impedes the performance of obligations under the grant contract, which the parties could not have foreseen and which they could not have prevented or overcome by acting with due diligence.\ng.\tin the case of conditions in accordance with section 3.2.4. para. 4.b -e. Guidelines on the eligibility of expenditure for the period 2021-2027 para. 4.b -e.","created_at":"2024-03-26 12:05:58","modified_at":"2024-03-30 00:00:03","contact_persons":[{"id":57,"forename":"Aleksandra","surname":"Mazga\u0142a","phone_number":"+48 538 899 945","email":"tenders@ryvu.com","created_by":null,"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":null}],"orders":[{"id":399175,"estimated_value":null,"order_items":[{"id":450132,"description":"Part of the contract: Part 1\nName and CPV code:  48461000-7 Analytical or scientific software package.\nPurchase and delivery / granting of access to the license of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling software.\n\nThe contractor should provide the license for scientific software for compartmental (CA) and non-compartmental analysis (NCA), pharmacokinetic/pharmacodynamic (PK/PD) and toxicokinetic (TK) modelling and simulation as described below.\nThe minimum set of functionalities: \na)\tCriteria settings for calculations\nb)\tAcceptance criteria settings for quality control\nc)\tDefinition of custom parameters \nd)\tCustomization of workflows and PK/PD models\ne)\tEditing of plots, figures and tables\nf)\tTool provides automated calculation of NCA ratio\ng)\tUser-defined NCA parameters\nh)\tUser-friendly software providing modelling, statistical, graphical and data management tools\ni)\tIncludes libraries of PK/PD models and workflows\nj)\tPossible to lock workflow templates with password protection\nk)\tPost-purchase user support (online training, webinars, etc.)\t\nm)\tCompatible with Windows       \nLicense type: Annual named user license\nLicense term: 1 year, with the possibility of renewing the license for additional years during the duration of the Project.\nQuantity: 3 licenses: 2 with basic options, and 1 license additionally with a software validation tool, including a plugin enabling the execution of the following actions \na) Customizable population PK and PKPD analysis tool\nb) Non-linear mixed effects pharmacokinetic modelling and simulation software.\n\n\nIn case of discrepancies between the provisions of the announcement on the Competitive Database and the provisions of the RFQ in the PDF version, the PDF version of the enquiry attached to the announcement shall be binding.","warranty_period":null,"cpv_items":[{"id":7258,"code":"48461000-7","name":"Analityczne lub naukowe pakiety oprogramowania"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2024-03-26 12:05:58","modified_at":"2024-03-26 12:05:58","modified_by":null,"id":504728,"type":{"id":1,"name":"adres"},"group_uuid":"977174d4-a335-4e12-948a-3c3192032142"}],"participation_conditions":[{"id":1233263,"description":"The evaluation of the conditions for participation in the procedure is carried out according to the meet-not meet system.\nDue to the prohibition of conflicts of interest, Contractors with personal or capital ties to the Ordering Party are excluded from the procedure. Equity or personal relationship is understood as relations between the Ordering Party or individuals authorized to take commitments on behalf of the Ordering Party or those acting on behalf of the Ordering Party in order to prepare and implement the contractor selection procedure, and the Contractor, including in particular:\na.\tparticipation in a company as a partner in a civil law partnership or a partnership, holding at least 10% of shares (unless a lower threshold is specified by law), being a member of a supervisory or managerial body, a proxy, a proxy, \nb.\tthey are married, in a relationship of kinship or affinity in a straight line, or in a relationship of kinship or affinity in the collateral line to the second degree, or in a relationship of adoption, custody or guardianship, or in a shared life relationship with the economic operator, its legal deputy, or members of the management or supervisory bodies of contractors applying for the award of the contract, \nc.\tthey have such a legal or factual relationship with the economic operator that there is a reasonable doubt as to their impartiality or independence in connection with the contract award procedure.\nAssessment of the fulfillment of the above-mentioned condition will be made on the basis of a declaration of the Ordering Party.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2024-03-26 12:05:58","modified_at":"2024-03-26 12:05:58","modified_by":null,"group_uuid":"fbb1b609-f70f-4f60-bf6e-4fda4a77be43"}],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2024-03-26 12:05:58","modified_at":"2024-03-26 12:05:58","modified_by":null,"group_uuid":"81a064f5-b72a-44e5-8c96-21a98742d649"}],"evaluation_criteria":[{"id":686380,"price_criterion":true,"description":"Net price (\u2018C\u2019) - weight: 100% (10 points)","created_by":null,"created_at":"2024-03-26 12:05:58","modified_at":"2024-03-26 12:05:58","modified_by":null,"group_uuid":"4a565e4b-1414-4785-9c02-5a73359f16e9"}],"is_variant":false,"title":"License","order_node":{"id":302495},"created_by":null,"created_at":"2024-03-26 12:05:58","modified_at":"2024-03-26 12:05:58","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":{"id":112,"contact_persons":[]},"created_at":"2024-03-26 12:05:58","modified_at":"2024-03-26 12:05:58","modified_by":{"id":112,"contact_persons":[]},"id":657147,"street":"Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2024-03-26 12:05:58","modified_at":"2024-03-26 12:05:58","modified_by":{"id":112,"contact_persons":[]},"id":246557},"advertisement":{"id":186952,"number":"2024-112-186952","publication_date":"2024-03-22","created_by":{"id":112,"contact_persons":[]},"created_at":"2024-03-22 17:04:51","modified_at":"2024-03-30 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[245818,245819,245821,246004],"enrollment":{"id":39917,"name":"Rozw\u00f3j celowanej terapii przeciwnowotworowej opartej o zahamowanie helikazy WRN (CanSL)","number":"002/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-002/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-07-17 12:04:06","modified_at":"2023-07-17 12:04:06","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":245819,"publication_date":"2024-03-22"},"id":1271965,"name":"Zapytanie ofertowe - RFQ 22 03 2024 WN","file":{"id":1418113,"name":"RFQ 22 03 2024 WN.pdf","created_at":"2024-03-26 12:05:58","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1418113"},"group_uuid":"751ffeb6-ac60-4c84-9d25-d34019ed968b"},{"origin":{"id":245819,"publication_date":"2024-03-22"},"id":1271966,"name":"Formularz oferty - OFFER FORM 22 03 2024 WN","file":{"id":1418114,"name":"OFFER FORM 22 03 2024 WN.docx","created_at":"2024-03-26 12:05:58","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1418114"},"group_uuid":"c2b9a308-72f3-462d-8142-71b1832290f4"},{"origin":{"id":245821,"publication_date":"2024-03-22"},"id":1271972,"name":"Zapytanie ofertowe aktualizacja1 - RFQ 22 03 2024 WN_updated1","file":{"id":1418119,"name":"RFQ 22 03 2024 WN_updated1.pdf","created_at":"2024-03-26 12:05:58","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1418119"},"group_uuid":"8c1ed79f-a4d8-4fbf-83d1-3c64f05f7917"},{"origin":{"id":245821,"publication_date":"2024-03-22"},"id":1271973,"name":"Formularz ofertowy aktualizacja1 - OFFER FORM 22 03 2024 WN_updated1","file":{"id":1418121,"name":"OFFER FORM 22 03 2024 WN_updated1.docx","created_at":"2024-03-26 12:05:58","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1418121"},"group_uuid":"929f4381-19d1-436e-9b7a-b327115b3fd5"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}